Enlivex Ltd. (ENLV) vs Moleculin Biotech, Inc. (MBRX)

Enlivex Ltd. and Moleculin Biotech, Inc. are both Biotechnology companies. Enlivex Ltd. and Moleculin Biotech, Inc. are of similar size ($11.3M and $11.2M). Enlivex Ltd. trades at the lower P/E: 0.0× against 0.1×. Across the 12 metrics below, Enlivex Ltd. leads on 9 and Moleculin Biotech, Inc. on 3.

Valuation

Metric ENLV MBRX Biotechnology median
P/E 0.00 0.05 7.88
P/S n/m n/m 11.47
P/B 0.00 0.29 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 118.16 0.11 0.74
EV/Sales n/m n/m 10.73
Earnings yield 67,549.40% 1,870.40% (28.84%)
Free cash flow yield (573.24%) (746.71%) (23.03%)

Profitability

Metric ENLV MBRX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 126.17% (1,471.05%) (57.72%)
Return on assets 104.94% (152.41%) (49.22%)
Return on invested capital (4.78%) (417.27%) 0.00%

Growth

Metric ENLV MBRX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 3,590.26% 82.01% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV MBRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 193.24 0.94 4.73
Net debt to EBITDA 118.29 0.35 0.96

Dividend

Metric ENLV MBRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENLV MBRX Biotechnology median
Market cap 11.33m 11.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack